A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis
Clinical trial NCT03827200 · TERMINATED
Trial details
- NCT number
- NCT03827200
- Sponsor
- Noorik Biopharmaceuticals AG
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-11
- Primary completion
- 2020-12-29
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.